BioSpace News Archive

Pharm Country

Establishment Labs Announces Participation in Two Upcoming Investment Conferences - May 23 2024

Establishment Labs Holdings Inc. today announced its participation in two upcoming investment conferences.

May 23, 2024
·
2 min read
Biotech Bay

Radar Therapeutics Raises $13.4M in Seed Funding to Develop Smart Programmable Medicines Using Molecular RNA Sensors

Radar Therapeutics today announced the completion of an oversubscribed $13.4 million in seed financing led by NfX Bio.

May 23, 2024
·
4 min read
Genetown

Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress

Astria Therapeutics, Inc. today announced that it will present two posters at the upcoming European Academy of Allergy and Clinical Immunology (EAACI) Congress in Valencia, Spain on June 1, 2024.

May 23, 2024
·
1 min read
BioForest

Indapta Therapeutics to Highlight its g-NK Cell Platform for the Treatment of Cancer and Autoimmune Disease in a Plenary Session at New York Academy of Sciences Frontiers in Cancer Immunotherapy Conference

Indapta Therapeutics, Inc. announced that CEO Mark Frohlich, MD, will be giving a plenary talk today titled, “g-NK cells for the treatment of cancer and autoimmune disease” at the New York Academy of Sciences Frontiers in Cancer Immunotherapy Conference.

May 23, 2024
·
3 min read
Pharm Country

Neuronetics to Present at the William Blair 44th Annual Growth Stock Conference

Neuronetics, Inc. today announced that the management team will present at the William Blair 44th Annual Growth Stock Conference on Thursday, June 6, 2024.

May 23, 2024
·
1 min read
Genetown

Yield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide Label

Yield10 Bioscience, Inc. today announced that UPL Ltd. (“UPL”) has received U.S. Environmental Protection Agency (“EPA”) approval to amend the label language of INTERLINE ® Herbicide to include the oilseed Camelina sativa (“Camelina”).

May 23, 2024
·
4 min read
Biotech Bay

Allogene Therapeutics Announces Participation in the TD Cowen 5th Annual Oncology Innovation Summit

Allogene Therapeutics, Inc. today announced it will participate in the TD Cowen 5th Annual Oncology Innovation Summit.

May 23, 2024
·
2 min read
Genetown

Inozyme Pharma to Present Recently Announced Data from Phase 1/2 Trials of INZ-701 in Adults with ENPP1 Deficiency and ABCC6 Deficiency (PXE) at Upcoming Medical Conferences

Inozyme Pharma, Inc today announced that the Company will present recently announced topline data during oral presentations at two upcoming medical conferences.

May 23, 2024
·
9 min read
Mirion to Present at Jefferies’ 2024 Global Healthcare Conference

Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Jefferies’ 2024 Global Healthcare Conference in New York, NY. The presentation will begin at 4:00 PM ET on Thursday, June 6, 2024.

May 23, 2024
·
1 min read
Business

NanoViricides Bolsters Partnership Efforts - Engages Aagami Inc.

NanoViricides, Inc. reports that it has engaged Aagami, Inc. for business development, specifically to seek licensing and partnering opportunities for our assets and platform technology.

May 23, 2024
·
9 min read